{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:14:44Z","timestamp":1790201684782,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Granulocyte-colony stimulating factor (G-CSF) is increasingly been used to prevent febrile neutropenia (FN) associated with the administration of chemotherapy for various cancers. The most common adverse effects of G-CSF are bone pain and injection-site reactions and aortitis has rarely been reported. We report herein a rare case of G-CSF associated with aortitis in a woman with advanced breast cancer.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 72-year-old woman with estrogen receptor-negative human epidermal growth factor 2-positive breast cancer with distant metastases in the lung was admitted. Her treatment was initiated with docetaxel in combination with trastuzumab and pertuzumab followed by the supportive use of a long-acting G-CSF, pegfilgrastim. After administration of pegfilgrastim on day 5, the patient had an intermittent fever (body temperature up to 39.6\u2009\u00b0C) on day 9 which continued irrespective of taking levofloxacin. She visited our outpatient clinic on day 13 with no objective symptoms other than fever. Laboratory tests revealed a high neutrophil count (15,000\/\u03bcl) and a high C-reactive protein (CRP) level (46.35\u2009mg\/dl) without any other abnormalities. There was no response upon administration of antimicrobial agents. An 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography (FDG-PET\/CT) revealed thickening of the wall of the descending thoracic aorta and left pleural effusion. Therefore, thoracic aortitis induced by pegfilgrastim was suspected. On day 19, the fever resolved spontaneously followed by a gradual reduction in the neutrophil count and CRP level. In the follow-up CT, the aortic wall thickness and pleural effusion had disappeared.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>G-CSF may cause aortitis due to stimulation of the production of inflammatory cytokines. In case of high continuous fever after administration of pegfilgrastim, aortitis should be suspected unless there are other infectious findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-019-6403-9","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T18:03:00Z","timestamp":1576519380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-7540","authenticated-orcid":false,"given":"Hideko","family":"Hoshina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"6403_CR1","first-page":"CD007913","volume":"10","author":"P Renner","year":"2012","unstructured":"Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database Syst Rev. 2012;10:CD007913.","journal-title":"Cochrane Database Syst Rev"},{"key":"6403_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cyto.2019.02.013","volume":"119","author":"Y Oshima","year":"2019","unstructured":"Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the Japanese adverse drug event report database. Cytokine. 2019;119:47\u201351.","journal-title":"Cytokine"},{"issue":"10","key":"6403_CR3","doi-asserted-by":"publisher","first-page":"E333","DOI":"10.1002\/ajh.25220","volume":"93","author":"A Lardieri","year":"2018","unstructured":"Lardieri A, McCulley L, Christopher Jones S, Woronow D. Granulocyte colony-stimulating factors and aortitis: a rare adverse event. Am J Hematol. 2018;93(10):E333\u20136.","journal-title":"Am J Hematol"},{"issue":"4","key":"6403_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood.V90.4.1415","volume":"90","author":"D Pajkrt","year":"1997","unstructured":"Pajkrt D, Manten A, van der Poll T, Tiel-van Buul MM, Jansen J. Wouter ten Cate J, et al. modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood. 1997;90(4):1415\u201324.","journal-title":"Blood"},{"issue":"15","key":"6403_CR5","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.106.665570","volume":"115","author":"A Haghighat","year":"2007","unstructured":"Haghighat A, Weiss D, Whalin MK, Cowan DP, Taylor WR. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate arterosclerosis in apolipoprotein E-deficient mice. Circulation. 2007;115(15):2049\u201354.","journal-title":"Circulation"},{"issue":"5","key":"6403_CR6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1172\/JCI67356","volume":"123","author":"P Ye","year":"2013","unstructured":"Ye P, Chen W, Wu J, Huang X, Li J, Wang S, et al. GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency. J Clin Invest. 2013;123(5):2317\u201331.","journal-title":"J Clin Invest"},{"key":"6403_CR7","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.2169\/internalmedicine.55.6704","volume":"55","author":"M Umeda","year":"2016","unstructured":"Umeda M, Ikenaga J, Koga T, Koga T, Michitsuji T, Shimizu T, et al. Giant cell arteritis which developed after the administration of granulocyte-colony stimulating factor for cyclic neutropenia. Intern Med. 2016;55:2291\u20134.","journal-title":"Intern Med"},{"issue":"1","key":"6403_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41598-018-36825-y","volume":"9","author":"S Fukui","year":"2019","unstructured":"Fukui S, Kuwahara-Takaki A, Ono N, Sato S, Koga T, Kawashiri SY, et al. Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis. Sci Rep. 2019;9(1):688.","journal-title":"Sci Rep"},{"key":"6403_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.11.084","volume":"80","author":"E Bossone","year":"2016","unstructured":"Bossone E, Pluchinotta FR, Andreas M, Blanc P, Citro R, Limongelli G, et al. Aortitis. Vasc Pharmacol. 2016;80:1\u201310.","journal-title":"Vasc Pharmacol"},{"issue":"12","key":"6403_CR10","first-page":"1771","volume":"45","author":"T Chino","year":"2018","unstructured":"Chino T, Oba T, Yamamoto K, Takekoshi D, Iesato A, Ito T, et al. A Case of arteritis that developed after pegfilgrastim administration during chemotherapy for breast cancer. Jpn J Cancer Chemother. 2018;45(12):1771\u20134 (Japanese).","journal-title":"Jpn J Cancer Chemother"},{"issue":"6","key":"6403_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.autrev.2018.12.011","volume":"18","author":"I Parodis","year":"2019","unstructured":"Parodis I, Dani L, Notarnicola A, Martenhed G, Fernstr\u00f6m P, Matikas A, et al. G-CSF-induced aortitis: two cases and review of the literature. Autoimmun Rev. 2019;18(6):615\u201320.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"6403_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2165\/11530790-000000000-00000","volume":"29","author":"GU Adiga","year":"2009","unstructured":"Adiga GU, Elkadi D, Malik SK, Fitzpatrick JD, Madajewicz S. Abdominal Aortitis after use of granulocyte Colony-stimulating factor. Clin Drug Investig. 2009;29(12):821\u20135.","journal-title":"Clin Drug Investig"},{"issue":"5","key":"6403_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/ejcts\/ezx165","volume":"52","author":"Y Sato","year":"2017","unstructured":"Sato Y, Kaji S, Ueda H, Tomii K. Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardiothorac Surg. 2017;52(5):993\u20134.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"6403_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tjog.2018.08.026","volume":"57","author":"K Hiranuma","year":"2018","unstructured":"Hiranuma K, Kusunoki S, Fujino K, Hirayama T, Ota T, Terao Y. Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy. Taiwan J Obstet Gynecol. 2018;57(5):750\u20132.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"6403_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.revmed.2003.10.015","volume":"25","author":"C Darie","year":"2004","unstructured":"Darie C, Boutalba S, Fichter P, Huret JF, Jaillot P, Gerenton S, et al. Aortitis after G-CSF injections. Rev Med Interne. 2004;25(3):225\u20139 (French).","journal-title":"Rev Med Interne"},{"issue":"6","key":"6403_CR16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s10067-016-3253-6","volume":"35","author":"EB Miller","year":"2016","unstructured":"Miller EB, Grosu R, Landau Z. Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol. 2016;35(6):1655\u20137.","journal-title":"Clin Rheumatol"},{"key":"6403_CR17","unstructured":"Suzuki E, Iwadate H, Saito R, Kobayashi H, Watanabe H, Ohira H. A case of Aortitis syndrome that recurred after G-CSF administration (Japanese). Jpn J Clin Immunol. 2009;37:159."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6403-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:16:23Z","timestamp":1607991383000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6403-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6403"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6403-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"12 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"H.H informed the patient that clinical and personal details of the patient would be published on a journal, and a written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1217"}}